MedPath

Quantification of Microbiota in Health and Diseases

Conditions
Disease
Interventions
Diagnostic Test: quantification of microbiota
Registration Number
NCT03388424
Lead Sponsor
University of Catanzaro
Brief Summary

Microbiota consists of trillions of microorganisms located in all the biological cavity. The relationships between individual health status and microbiota are based on a sort of "mutual cooperation." The balance of the microbiota can be compromised by various factors such as environmental, psycho-physical stress, malnutrition (over or low), breastfeeding, chronic diseases, oncology and pharmacological treatments (especially antibiotics and chemotherapics). The impact of dysbiosis on today's society affects over 70% of the world population

Detailed Description

Intestinal microbiota is defined as the strongest modulator of the human genome and it is considered the "second brain" of our organism for its bi-directional communication with the central nervous system. Microbiota consists of trillions of microorganisms located in all the biological cavity, In the intestine it is distributed in ecological niches having multiple metabolic activities which influence individual health. Microbiota acts as barrier against pathogens, regulating the absorption of nutrients, the production of energy and the development of the immune system4. Intestinal bacteria are generally divided into 4 Phylum: Firmicutes, Actinobacteria, Proteobacteria and Bacteriodetes, in which their proportion shows a correlation with individuals health status. When in equilibrium among them, these bacteria are essential for the good health of the digestive tract, the good function of immune system and for brain performace. The relationships between individual health status and microbiota are based on a sort of "mutual cooperation." The balance of the microbiota can be compromised by various factors such as environmental, psycho-physical stress, malnutrition (over or low), breastfeeding, chronic diseases, oncology and pharmacological treatments (especially antibiotics and chemotherapics). This disequilibrium leads to altered capability of bacteria to properly extract calories from food affecting the trend of many pathophisilogical status such as obesity, allergic states, inflammatory bowel syndromes cardiovascular diseases, metabolic, oncological and neurodegenerative diseases. The impact of dysbiosis on today's society affects over 70% of the world population

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • all patients will be enclosed in each group in agreement with the characteristics of the groups
Exclusion Criteria
  • Patients who will not sign the informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
quantification of microbiota in Brainquantification of microbiotaPatients of both sex with neural disorders and diseases
Controlquantification of microbiotaHealthy people of both sex
quantification of microbiota in Lungquantification of microbiotaPatients of both sex with Respiratory diseases
quantification of microbiota in GIquantification of microbiotaPatients of both sex with gastrointestinal diseases
quantification of microbiota Metabolicquantification of microbiotaPatients of both sex with Metabolic Diseases
quantification of microbiota in UGquantification of microbiotaPatients of both sex with Uro-genital Diseases
Primary Outcome Measures
NameTimeMethod
Determination of microbiota percentage12 months

we will determine the difference of microbiota percentage in diseases-groups respect to control-group

Secondary Outcome Measures
NameTimeMethod
Determination of antibiotic resistance gene12 months

it will be evaluate the presence of antibiotic resistance gene in diseases-group respect to control-group

Trial Locations

Locations (1)

AO Materdomini

🇮🇹

Catanzaro, Italia, Italy

© Copyright 2025. All Rights Reserved by MedPath